Rivian Adventure Network fast charging launches in Colorado, California

WEBWIRE



Rivian opens three fast charging sites this week in Colorado and California, the first deployments in its nationwide Rivian Adventure Network. These “Level 3” DC fast charging sites will initially provide over 200 kilowatts of power, allowing Rivian drivers to add as much as 140 miles of range in just 20 minutes and creating new opportunities for sustainable adventure far from home.


The first Rivian Adventure Network site in Salida, Colorado opened to the public on Monday, June 27 with four chargers, including a pull-through charger to accommodate vehicles towing trailers. The site also hosts four “Level 2” Rivian Waypoints chargers, which are available for use by any EV – not just Rivian vehicles – through the Rivian smartphone app. Thanks to its natural beauty and abundant nearby recreational opportunities, Salida is an ideal location for Rivian’s first fast charging site. The second and third Adventure Network sites in Inyokern and Bishop, California, will open on June 28 and 29. These California sites support frequently visited areas like Yosemite National Park, Sequoia National Forest, Mammoth Lakes, and Death Valley National Park.


“We designed Rivian charging to support electrified adventure, and these first sites demonstrate how we’re enabling drivers to responsibly reach some of the nation’s most breathtaking natural spaces,” said Trent Warnke, Rivian’s Senior Director of Energy and Charging Solutions. “In addition to scenic or off-the-beaten-path destinations, our fast charging rollout is designed to ensure travelers have places to charge along major transportation corridors coast to coast.”


Recognizing that vehicle electrification is only one step in reducing environmental impact, Rivian is matching charging on Rivian Adventure Network and Waypoints chargers with 100% renewable energy on an annual basis. Rivian is engaging directly with clean energy developers and operators to promote tangible contributions to a cleaner grid when drivers plug in. To support this initiative, Rivian is building a portfolio of high-impact renewable projects around the country that balance technologies, location, and energy solutions. Integrating these solutions into a company-wide sustainability strategy is a foundational step on our path toward net-zero carbon emissions.


Rivian will continue opening Rivian Adventure Network sites with an initial goal of 3,500 fast chargers at 600 sites across North America.


Forward-Looking Statements


This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the expansion of the Rivian Adventure Network. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “forecasts,” “predicts,” “potential,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements use these words or expressions. These forward-looking statements speak only as of the date when made, and we undertake no obligation to publicly update or revise any forward-looking statements after the date of this press release, except as required by applicable law. Forward-looking statements are not guarantees of future performance and inherently involve a wide range of risks and uncertainties that are difficult to predict. A discussion of these risks and uncertainties is contained in our filings with the Securities and Exchange Commission.


About Rivian


Rivian exists to create products and services that help our planet transition to carbon neutral energy and transportation. Rivian designs, develops, and manufactures category-defining electric vehicles and accessories and sells them directly to customers in the consumer and commercial markets. Rivian complements its vehicles with a full suite of proprietary, value-added services that address the entire lifecycle of the vehicle and deepen its customer relationships. Learn more about the company, products, and careers at rivian.com.

Stellantis, in Collaboration With ProMedica Health System, Establishes a Primary Care Health and Wellness Center in Toledo, Ohio

Auburn Hills, Mich. – WEBWIRE



  • The Stellantis Family Health and Wellness Center delivered by ProMedica is a primary care, near-site health facility established exclusively to serve Stellantis employees and their covered family members
  • Center to provide personalized health care experience through comprehensive services and wellness programs
  • Stellantis, in partnership with the UAW, was first domestic automaker to establish near-site health clinic for its employees and their families
  • Toledo is fourth health and wellness center opened by company, following sites in Kokomo, Indiana; Belvidere, Illinois; and Detroit
  • Center to start seeing patients in July
  • Nationally, ProMedica provides care at six on-site/near-site health and wellness centers, representing 13 employer clients



Stellantis today announced the opening of a comprehensive primary care health and wellness center in Toledo, Ohio, exclusively for the more than 9,500 employees and their families working and living within a 15-mile radius of the facility.

 

With a focus on keeping people well, Stellantis is collaborating with ProMedica Health System to provide a personalized, comprehensive health and wellness experience supported by a leading and respected health system in a new, state-of-the-art medical center.

 

Opening to employees and their families in July, this new health and wellness center provides easy access to such services as preventative and acute care, chronic disease management, infant/pediatric care, women’s health services, behavioral health services, physical therapy, nutrition and health education coaching, advanced medical diagnostics, virtual care options, pharmacy services and more.



“As a global automaker and mobility provider with a diverse and talented workforce, Stellantis understands that investing in our employees’ health and well-being is good business,” said Tobin J. Williams, senior vice president for human resources, Stellantis North America. “Our goal in opening this facility is to improve our employees’ access to quality and convenient health care.” 

 

The 12,000-square-foot health and wellness center, located at 3500 Executive Parkway, will feature 13 examination rooms along with eight consultation, lab and treatment rooms and a large physical therapy area. It will provide a convenient, low- to no-cost option for acute, preventative and wellness-focused primary care services for all Stellantis employees and their covered family members enrolled in the company’s health care plans.



UAW-represented employees will not be charged any office visit co-pays when they use the services offered by the clinic. And, as a non-traditional medical office, appointment times are expected to be longer to ensure adequate time to address each patient’s medical needs.



“We are excited to be partnering with Stellantis on a top-notch, dedicated family health and wellness center for its northwest Ohio employees,” said Kent Bishop, MD, president, ProMedica Physicians and chief medical officer for ProMedica Physicians, pharmacy and acute care. “ProMedica’s expert care team is committed to helping Stellantis employees and their eligible family members improve their health and well-being by providing coordinated, customized and convenient primary care and wellness services. With the potential to provide patient cost-savings benefits and encourage a healthier workforce, this new clinic presents a win-win situation for Stellantis and its local employees.”



Featuring same-day appointments, extended hours and virtual care options, the center will connect employees with multiple primary care providers and needed wellness services. Care plans will focus on a comprehensive approach to wellness across lifestyle, fitness and medical integrations, providing a unique opportunity for managing chronic conditions such as hypertension and diabetes.

 

ProMedica currently provides care at six on-site/near-site health and wellness centers, representing 13 employer clients. ProMedica has more than 1,200 physicians and advanced practice providers with 2 million patient visits each year across Ohio and Michigan.

 

Stellantis, with support from the UAW, was the first domestic automaker to establish a near-site health and wellness center with the opening of a site in Kokomo, Indiana, in 2018. Toledo is the fourth center opened by the company, which also includes sites in Belvidere, Illinois, and in Detroit, Michigan.



“With high per capita health care costs and difficulties for employees accessing primary care services, Stellantis looks forward to ProMedica delivering an easy-to-access, personalized and distinct health care experience,” said Stellantis’ Williams.



Stellantis Health and Wellness

A long-established innovator in providing programs and services to support the health and wellness of employees and families, Stellantis has been recognized nine consecutive years by the National Business Group on Health for programs that enable a healthy workplace and encourage healthy lifestyles for both employees and families. Stellantis is committed to “4URHLTH,” a program designed to support overall well-being that empowers employees and their families with access to comprehensive tools and resources for leading healthier lifestyles.



Since 1985, the company’s wellness program has evolved to meet the needs of employees and their families. Today, Stellantis provides a variety of integrated health plans with preventive services, including access to health portals, UAW benefit representatives, a health advocate for salaried employees, an Employee Assistance Program representative for all employees, on-site medical departments, 29 dedicated wellness staff members and fitness centers.

 

ProMedica Health System

ProMedica is a mission-based, not-for-profit health and well-being organization headquartered in Toledo, Ohio. It serves communities in 28 states. The organization offers acute and ambulatory care, an insurance company with a dental plan, and post-acute and academic business lines. The organization has more than 43,000 employees, 12 hospitals, 2,500+ physicians and advanced practice providers with privileges, 1,000+ healthcare providers employed by ProMedica Physicians, a health plan, and 335+ assisted living facilities, skilled nursing centers, memory care communities, outpatient rehabilitation clinics, and hospice, palliative and home health care agencies. Driven by its Mission to improve your health and well-being, ProMedica has been nationally recognized for its advocacy programs and efforts to address social determinants of health. For more information about ProMedica, please visit promedica.org/aboutus.

Tianda Pharmaceuticals Annual Results 2022

Tianda Pharmaceuticals Limited (Tianda Pharmaceuticals or the Group, stock code: 0455.HK) is pleased to announce its annual results for the year ended 31 March 2022. During the Reporting Period, the Group’s business attained further development as revenue reached HK$510.0 million for the Current Financial Year, representing an increase of 7.5% compared to last year. Innovation and R&D made steady progress with R&D expenses increasing 34.7% year on year (YOY) to HK$15.9 million. With cash and cash equivalents of approximately HK$334.0 million as of 31 March 2022, the Group has sufficient financial resources to support its business development. To celebrate the 10th anniversary of the change of the Group’s name to “Tianda Pharmaceuticals Limited”, the Board of Directors recommended the payment of a final dividend of HK0.26 cent per share and a special dividend of HK0.56 cent per share to reward its shareholders for their support and trust over the years.
The Pharmaceuticals and medical technologies business revenue reached HK$396.1 million, an increase of 10.7% YOY. The Group focuses on products and technology, actively introducing, developing and acquiring innovative drugs, generic drugs, healthcare products, and medical devices for cardiovascular and cerebrovascular, women and children, and respiratory system diseases, oncology and rehabilitation. The Group’s major product, Tuoping Valsartan capsules, a medicine for cardio-cerebrovascular disease, became the No. 1 product in its category in China by sales quantity as it seized the opportunity of the success in securing first place in the nation’s Third Round of Centralized Drug Procurement with Target Quantity to supply nationwide, which increased both sales and brand awareness. Through the integration of sales teams and channels, the Group’s medicines, especially the pediatric drugs, Tuoen Ibuprofen oral suspension and Ibuprofen suspension drops, also achieved satisfactory sales growth. The Group’s new R&D and production base in Jinwan, Zhuhai has commenced operations, with an investment of HK$430 million for the first phase of the development and is equipped with imported and domestic advanced automated equipment. The new base is poised to become a pharmaceutical and health industry base with high standard, quality and efficiency through innovation development, accelerated product lines enrichment and production capacity improvement. Five CDMO/CMO contracts have been successfully signed.

The Chinese medicine business revenue reached HK$106.5 million, down 4.9% YOY. In the first nine months of the Reporting Period, the Chinese medicine business achieved faster growth by utilizing various methods to form mutually beneficial cooperation with partners such as medicinal materials farmers, cooperatives, distributors and pharmaceutical companies for building a nationwide and global business network for the Chinese medicinal materials business. Going forward, the Group will adopt a variety-centric approach to focus on domestic and overseas trading of Chinese medicinal materials, production and sales of TCM decoction pieces and formula granules, and distribution business, integrating quality resources from upstream to downstream for the industry.

The Medical and healthcare services revenue reached HK$7.4 million, an increase of 57.4% YOY. The Group steadily advances the development of the modern Chinese medical clinic “TDMall” through self-construction, franchising and mergers and acquisitions. The priority is to expand in the Guangdong-Hong Kong-Macao Greater Bay Area while making plans for a national and global rollout. TDMalls have been opened in Zhuhai, Hong Kong and Sydney successively since 2019 with the aim to build the global chain operation model under three different local laws and regulations for Chinese medicine. Meanwhile, Zhuhai TDMall became the first Chinese medicine clinic in the world to receive both the ISO 9001:2015 Quality Management System Certification and Qualicert International Service Quality Certification. As part of its caring for people’s health and CSR initiatives, the Group launched the “TDMall Cloud-based Global Anti-epidemic Chinese Medicine Platform” amid the fifth wave of the COVID-19 pandemic in Hong Kong in early 2022 to support the Group’s “Free Consultation and Medicine” charity campaign to provide the public with comprehensive remote Chinese medicine services from prevention, treatment to rehabilitation, as well as Chinese medicine services for mitigating long COVID.

China’s “14th Five-Year Plan” proposes to comprehensively promote the construction of a healthy China, placing the protection of people’s health as a strategic priority for development and providing people with comprehensive life-cycle health services. Adhering to the corporate slogan of “Tianda for Health!”, the Group will continue to execute the strategy of “development of Chinese medicine business as a foundation, development of innovative drugs and medical technologies, as well as development of quality medical and healthcare services”, implementing the “3D+1S” initiatives (business development (BD), research and development (R&D), investment and development (ID), and marketing & sales (S)) working in tandem to continuously enrich product lines and improve the quality and quantity of R&D projects in the pipeline through an external introduction, R&D, and mergers and acquisitions (M&A), as well as to identify cutting-edge technologies and products and quality projects worldwide in an effort to achieve high-quality development, so as to make a greater contribution to safeguarding the health of mankind.

About Tianda Pharmaceuticals Limited
Tianda Pharmaceuticals Limited is engaged in the development of the Chinese medicine business as a foundation, development of innovative drugs and medical technologies, as well as development of quality medical and healthcare services, committed to becoming a leading pharmaceutical enterprise that sets its footholds in China while expanding its presence worldwide.

For enquiries
Tianda Pharmaceuticals Limited
Investor Relations Department
Phone: +852 2545 3313
Email: ir@tianda.com






Topic: Press release summary

EC Healthcare and Yoho Group Form Strategic Partnership

EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group signed a memorandum of understanding with Yoho Group Holdings Limited (“Yoho Group”, SEHK stock code: 2347) for strategic collaboration. The partnership will be focused on accelerating the growth of medical, aesthetic medical and beauty and wellness services in the e-commerce market, and jointly boosting the e-commerce penetration of medical, aesthetic medical and beauty and wellness services in Hong Kong. The partnership will strengthen ECH’s online presence in Hong Kong and expand its customer base and further consolidate the leading market position.

Under the collaboration, (i) The Group will become Yoho Group’s anchor merchant in beauty and healthcare services and Yoho Group will launch an online medical, aesthetic medical and beauty and wellness service zone. The dedicated section will enable the Group to reach a greater public domain traffic flow from the e-commerce platform with strong client synergy in the healthcare and beauty sector;(ii)Both Parties will strengthen their co-marketing efforts to increase the overall sales volume and promote product cross-sell; (iii) Both Parties agree to exchange know-how in precision marketing and consumer behavior analysis in healthcare and beauty sector, in order to develop more comprehensive digitalized marketing strategy to improve overall customer lifetime value; (iv) Both Parties will devote resources to jointly enhance technical solutions across social & mobile commerce, data-driven marketing, and fulfillment efficiency to streamline the entire consumer journey.

Mr. Gemini Wong, Executive Director, Chief Digital Officer and Deputy Marketing Officer of EC Healthcare said, “The Group is delighted to establish a strategic partnership with Yoho Group. Through the collaboration, we hope to leverage Yoho Group’s experience regarding online retail and the extensive reach to the accumulated customer traffic to boost the Group’s e-commerce, diversify the digital marketing strategies and optimize the e-commerce experience so as to increase the overall sales volume, and raise the brand awareness and consolidate the leading position.”

About EC Healthcare
EC Healthcare is Hong Kong’s largest non-hospital medical service provider*, focusing on preventive and precision medicine and leveraging investment in IT, brand, service and corporate culture to build a diversified enclosed healthcare ecosystem with the mission to bring health, beauty and happiness to everyone. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.

The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, a advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.

*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021

About Yoho Group Holdings Limited
Yoho Group Holdings Limited is one of the leading e-commerce platforms in Hong Kong, with more than 820,000 registered users as of the date of this announcement and over 2,290,000 monthly active users (based on the data in March 2022). According to Frost & Sullivan’s data and the Group’s revenue for the financial year ended 31 March 2021, the Group recorded the highest online retail sales among e-commerce players in consumer electronics and home appliances and acquired a market share of approximately 5.6%. Leveraging its vast customer base, the Group is expected to launch its online marketplace operations in the financial year ending 31 March 2023 to expand the product and service offerings for its customers.






Topic: Press release summary

Indonesian calls, messages at G7 Summit

Indonesian President Joko Widodo (Jokowi) has arrived at the venue of the 48th G7 Summit in Schloss Elmau, Germany on Monday afternoon (June 27) local time (UTC+1) to attend the meeting in the capacity of a partner country and as the G20 President.

Indonesian President Joko Widodo in conversation with French President Emmanuel Macron and United States President Joe Biden while attending the G7 Summit in Elmau, Germany, Monday, June 27, 2022. ANTARA/HO-Press Bureau of the Presidential Secretariat/Laily Rachev/aa/ak. (Handout of Press Bureau of the Presidential Secretariat/Laily R)

The G7 is an informal forum bringing together leaders of the world’s leading industrial nations from the European Union and countries such as Canada, France, Germany, Italy, Japan, the United Kingdom, and the United States.

Jokowi was welcomed by German Chancellor Olaf Scholz.

During the official welcoming session by the chancellor, Jokowi was present with the leaders of G7 partner countries, including Argentine President Alberto Fernandez, Indian Prime Minister Narendra Modi, Senegalese President Macky Sall, and South African President Cyril Ramaphosa.

Furthermore, during the photo session, he posed for a picture accompanied by the German chancellor and United States President Joe Biden.

All heads of government attended two sessions of the G7 meeting.

President Jokowi invited G7 countries to contribute to capitalizing on investment opportunities in the clean energy sector in Indonesia.

President Jokowi conveyed the statement while attending the G7 Summit working lunch session based on the topics of climate change, energy, and health in Elmau, Germany, Monday (June 27).

“(This is) especially (regarding) investment opportunities in the clean energy sector in Indonesia, including the development of an electric car and lithium battery ecosystem,” the president stated.

According to President Jokowi, Indonesia’s potential, as a contributor to clean energy, whether in the bowels of the earth, on land, or at sea, is very large. Indonesia needs large investments and low-carbon technologies to support a fast and effective transition to clean energy.

“Indonesia needs at least US$25-30 billion for energy transition in the next eight years. We can optimize this transition as a motor of economic growth, open up business opportunities, and create new jobs,” President Jokowi stated.

Furthermore, the president noted that in Indonesia as well as in other developing countries, the risk of climate change is very real, especially since it is an archipelagic country, with 17 thousand islands. The risks are not only detrimental to health but also put farmers and fishermen in trouble.

“We really hope for the support of all G7 countries in the Indonesian Presidency at the G20. See you in Bali. Thank you,” the president stated.

During session II of the G7 summit on the topics of food security and gender equality, President Jokowi called on G7 and G20 countries to jointly overcome the food crisis that currently threatens people in developing countries to fall into extreme hunger and poverty.

“(Some) 323 million people in 2022, according to the World Food Programme, are at risk of facing acute food insecurity. The G7 and G20 have a big responsibility to overcome this food crisis. Let us fulfill our responsibilities now and from now on,” President Jokowi affirmed.

According to the president, food is the most basic human rights issue. Indubitably, women from poor families suffer the most from food shortages for their children and families.

“We must act quickly to find a concrete solution. Food production must be increased. The global food and fertilizer supply chain must return to normal,” the president stated.

In his speech, President Jokowi emphasized the importance of G7 countries’ support for the reintegration of Ukraine’s wheat exports and Russia’s exports of food and fertilizer commodities in global supply chains.

There are two ways to realize this, with the first being the facilitation of Ukraine’s grain exports that can begin immediately.

According to the president, the second approach is proactive communication with the public worldwide that food and fertilizer commodities from Russia are not subject to sanctions.

“This intensive communication is very necessary, so that there is no prolonged doubt in the (minds of the) international public. This intensive communication also needs to be strengthened with communication with related parties, such as banks, insurance, shipping, and others,” the president explained.

President Jokowi had paid significant attention to the impact of the war on food and fertilizer supply chains.

“(This is) especially for fertilizers, because if we fail to handle it, then a rice crisis involving two billion people, especially in developing countries, can occur,” the president cautioned.

At the end of his remarks, the president again called for the importance of the G7 and G20 countries to jointly overcome this food crisis while also inviting G7 leaders to attend the G20 Summit in Bali.

“I am waiting for the G7 leaders to attend the G20 summit. See you in Bali, on November 15-16, 2022,” President Jokowi stated.

Meanwhile, Minister of Foreign Affairs Retno Marsudi noted that the president held about nine bilateral meetings with: the Prime Minister of India; French President; Prime Minister of Canada; Chancellor of Germany; British Prime Minister; Prime Minister of Japan; President of the European Commission; President of the Council of Europe; and the Managing Director of the IMF.

During the bilateral meetings, besides inviting other countries to solve the problems of the food supply chain, president Jokowi also highlighted the preparations for the G20 Summit.

“In these meetings, we can clearly see that support for the Indonesian Presidency is still very strong,” Marsudi noted.

In 2022, Germany takes over the G7 Presidency and hosts the 48th G7 summit held on June 26-28, 2022, in Schloss Elmau.

The G7, originally G8, was set up in 1975.

The annual G7 summits have, over the years, developed into a platform for determining the course of multilateral discourse and shaping political responses to global challenges.

Written by: Azis Kurmala, Editor: Fardah Assegaf (c) ANTARA 2022






Topic: Press release summary